ALUNBRIG

Identification of Alunbrig

No description

Google image searchProduct monograph

Active ingredient

brigatinib, 180 MG

DIN: 02479222

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: TAKEDA CANADA INC

Date: 31-AUG-2018

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01ED — Anaplastic lymphoma kinase (ALK) inhibitors (ATC, ATC/DDD)
• L01ED04 — BRIGATINIB (ATC/DDD)

Reference brand drug: Alunbrig

Pharmaceutical standard: MFR

External Links for Alunbrig

Search on Google

• Alunbrig side effects
• Alunbrig dosage
• brigatinib side effects
• brigatinib dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find alunbrig photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.